Related Experiment Video
Updated: Jun 23, 2026

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid
Published on: September 27, 2024
Facial acneiform rash associated with sorafenib
Beatriz Fleta-Asín1, Sergio Vañó-Galván, Alejandro Ledo-Rodríguez
1Dermatology Department, Ramon y Cajal Hospital, University of Alcalá de Henares, Madrid, Spain. beatriz_fleta@hotmail.com
Abstract:
Sorafenib is an oral multikinase inhibitor that is useful in the treatment of various solid cancer. We report a patient who developed an acneiform facial eruption during treatment with this medication.
Insights
Sorafenib, an oral multikinase inhibitor for cancer, can cause acneiform facial eruptions. This case report highlights a patient experiencing this specific side effect during treatment.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Sorafenib is a targeted therapy drug.
- It is used to treat various solid tumors.
- Understanding its side effects is crucial for patient management.
Observation:
- A patient undergoing Sorafenib treatment developed a facial rash.
- The rash presented as an acneiform eruption.
- This adverse event occurred during the course of therapy.
Findings:
- The patient's acneiform eruption was attributed to Sorafenib.
- This highlights a known but significant dermatological side effect of the drug.
- Monitoring for skin reactions is important in patients on Sorafenib.
Implications:
- Clinicians should be aware of this potential side effect.
- Early recognition and management of skin reactions can improve patient adherence and outcomes.
- Further research into managing Sorafenib-induced dermatopathies may be beneficial.
Related Concept Videos
Acne Infection
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Nephrotic Syndrome III : Nursing Management
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...